SME Times is powered by   
Search News
Just in:   • Indian firms making clean energy investments will reach better markets globally: PM Modi  • USTR, USDA say US farm exports roar back​  • PM Modi to address post-budget webinar on sustaining economic growth today  • Iran officially closes Strait of Hormuz, crude oil pices expected to soar  • India, Canada sign $2.6 billion uranium deal, aim for year-end deadline on FTA 
Last updated: 01 Feb, 2017  

cadila.thumb.jpg Cadila Healthcare net profit declines 34.6 pc in Q3

cadila.jpg
   Top Stories
» Iran officially closes Strait of Hormuz, crude oil pices expected to soar
» Sensex, Nifty drop over 1 pc over heightened Middle East tensions
» Market weekly roundup: Sensex, Nifty slip as global tensions weigh on sentiment
» Govt launches casebook on AI and gender empowerment
» India concludes 9 FTAs, gives businesses more access to global trade: Piyush Goyal
SME Times News Bureau | 01 Feb, 2017
Global pharmaceutical company Cadila Healthcare on Tuesday posted a 34.6 percent decline in its consolidated net profit to Rs 281.6 crore for the quarter ended December 31, 2016 as compared with Rs 430.5 crore in the year-ago period.

The company's consolidated total income from operations also dipped to Rs 2,363.8 crore during the quarter under review as compared with Rs 2,408.9 crore in a year-ago period.

On BSE, the stock settled at Rs 349.25, down 7.02 percent from the previous close.
 
Print the Page Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
₹91.35
89.65
UK Pound
₹125.3
₹121.3
Euro
₹108.5
₹104.85
Japanese Yen ₹58.65 ₹56.8
As on 19 Feb, 2026
  Daily Poll
What is your primary "Make or Break" expectation from the Finance Minister this year?
 The Tax Relief
 The Working Capital Fix
 The Compliance Holiday
 The Payment Shield
 The Tech Subsidy
 All
  Commented Stories
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter